Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2 N0M0 medical inoperable non-small cell lung cancer

Acta Oncologica

Volumn 45, Issue 7, 2006, Pages 973-977

  Djärv, Emma ^a   Nyman, Jan ^a   Baumann, Pia ^b   Ekberg, Lars ^c   Høyer, Morten ^d   Lax, Ingmar ^b   Lewensohn, Rolf ^b   Levin, Nina ^e   Lund, Jo Åsmund ^e   Morhed, Elisabeth ^f   Ericsson, Susanne Rehn ^f   Traberg, Anders ^d   Wittgren, Lena ^c   Johansson, Karl Axel ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LUNG NON SMALL CELL CANCER; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT PLANNING; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE II AS TOPIC; GUIDELINE ADHERENCE; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; RADIATION DOSAGE; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TUMOR BURDEN;

EID: 33748882206     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860600919241     Document Type: Conference Paper

References (10)

1. Blomgren H, Lax I, Göransson H, Kraepelien T, Nilsson B, Näslund I, et al. Radiosurgery for tumours in the body: Clinical experience using a new method. J Radiosurgery 1998;1:63-74.
2. Lax I, Blomgren H, Larsson D, et al. Extracranial stereotactic radiosurgery of localised targets. J Radiosurgery 1998; 1:135-48.
3. Lax I. Target dose versus extratarget in stereotactic radiosurgery. Acta Oncol 1993;32:453-7.
4. Johansson KA, Hansson WF, Horiot JC. Workshop of the EORTC Radiotherapy group on quality assurance in cooperative trials of radiotherapy: A recommendation for EORTC Cooperative groups. Radiother Oncol 1998;11: 201-3.
5. Van Tienhoven G, van Bree NAM, Mijnher BJ, Bartelink H. Quality assurance of the EORTC trial 22881/10882. Assessment of the role of booster dose in breast conserving therapy: Dummy run. Radiother Oncol 1991;22:290-8.
6. Dusserre A, Garavaglia G, Giraud JY, Bolla M. Quality assurance of the EORTC radiotherapy trial 22863 for prostatic cancer: The dummy run. Radiother Oncol 1995; 36:229-34.
7. International Commission on Radiation Units and Measurement, ICRU, Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50), Report 62, Washington DC, 1999.
8. Washington University in ST Louis. Computational Environment for Radiotherapy Research, CERR, 2003. http://radium.wustl.edu/CERR/about.php.
9. Valley JF, Bernier J, Tecier PA, et al. Quality assurance of the EORTC radiotherapy trial 22931 for head and neck Carcinomas: The dummy run. Radiother Oncol 1998;47:37-44.
10. Radiation Therapy Oncology group, RTOG A phase II trial of stereotactic body radiation therapy in the treatment of patients with medically inoperable stage I/II none small cell lung cancer. 2004. http://www.rtog.org/members/ protocols/0236/0236.pdf